Evaluation of vinburnine in pharmaceuticals by smart spectrophotometric methods; full stability study

• Published in: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Molecular and biomolecular spectroscopy, 2021-03, Vol.249, p.119209, Article 119209
• Main Authors: Abdelwhab, Nada S., Emam, Aml A., Habib, Neven M., Mahmoud, Hamada M., Abdelrahman, Maha M.
• Format: Article
• Language: English
• Subjects: Advanced absorbance subtraction; Degradation profile; Derivative amplitude factor; Dual wavelength resolution; Factorized absorbance difference; Vinburnine
• ISSN: 1386-1425
• DOI: 10.1016/j.saa.2020.119209

[Display omitted] •Complete stability study of vinburnine for the first time.•Stability indicating spectrophotometric assay methods.•The developed methods do not need any special program. Vinburnine (VNB) is a vinca alkaloid used as a vasodilator to enhance cerebral circulatory insufficiency. It is a cyclic amide containing drug which is expected to be sensitive to hydrolytic degradation. The degradation profile of VNB was studied in this work following ICH recommendations for stability study. The drug was sensitive only to degradation with NaOH with the formation of the carboxylic acid derivative, identified by IR and 1H NMR analyses as 2-((1S,12bS)-1-ethyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a] quinolizin-1-yl) acetic acid, (DEG). In this study five simple, smart and univariate stability indicating spectrophotometric methods were developed and validated for simultaneous determination of VNB and DEG for the first time. The developed methods include; Dual Wavelength Method (DWM), Dual Wavelength Resolution Method (DWRM), Factorized Absorbance Difference Method (FADM), Advanced Absorbance Subtraction Method (AASM), and Derivative Amplitude Factor Method (DAFM). These methods were capable of determination of VNB and DEG over the ranges of 1–30 and 3–50 µg/mL, respectively. The proposed methods were simple, smart, specific, and could be applied for analyzing synthetic mixtures of VNB and DEG and were successfully applied for determination of the drug in commercially available capsules. The obtained results of these methods were statistically compared with the reported HPLC one using student's-t and F- tests, where no significant difference was observed. Validation of the developed methods was applied according to ICH recommendations and all the results were within the acceptable limits.